Abstract
A review of the world literature regarding the relative efficacy, duration and toxicity of the available beta-adrenergic bronchodilator aerosols for the treatment of asthma is presented. Many of these agents will soon become available in the United States and some familiarity with their actions is necessary for optimal care of asthmatic patients.
摘要
本文综述了世界文献中关于现有β-肾上腺素能支气管扩张气雾剂治疗哮喘的相对疗效、作用持续时间和毒性。其中许多药物很快将在美国上市，为了对哮喘患者进行最佳护理，有必要对它们的作用有所了解。
Zotero 插件